• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

估算肾小球滤过率估计值检测的报告中,肌酐清除率检测的报告减少。

Reporting of the estimated glomerular filtration rate decreased creatinine clearance testing.

机构信息

Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.

出版信息

Kidney Int. 2012 Jun;81(12):1245-7. doi: 10.1038/ki.2011.483. Epub 2012 Feb 15.

DOI:10.1038/ki.2011.483
PMID:22336989
Abstract

The Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines suggest that clinicians use the estimated glomerular filtration rate (eGFR) measurements and minimize the use of timed urine creatinine clearance collection. The intent of this change was to improve recognition of chronic kidney disease. Here we used time-series modeling and intervention analyses to determine the effect of publication of the K/DOQI guidelines and the introduction of widespread eGFR reporting with prompts on physician ordering of 24-h urine collection for creatinine clearance. In this setting, clinical practice guidelines did not influence creatinine clearance testing; however, the direct introduction of eGFR reporting with prompts into physician workflow resulted in a sudden and significant 23.5% decrease in creatinine clearance collection over the 43 months analyzed. Thus, eGFR reporting with prompts may have produced a clinical practice change because it is integrated directly into physician workflow. Changing physician practice patterns may require more than publishing guidelines; rather it is more likely to occur through educational and structural changes to practice.

摘要

肾脏病预后质量倡议(K/DOQI)指南建议临床医生使用估算肾小球滤过率(eGFR)测量值,并尽量减少使用定时尿肌酐清除率收集。这一改变的目的是提高对慢性肾脏病的认识。在这里,我们使用时间序列建模和干预分析来确定 K/DOQI 指南的发布以及广泛使用带有提示的 eGFR 报告对医生开具 24 小时尿液收集进行肌酐清除率检测的影响。在这种情况下,临床实践指南并没有影响肌酐清除率检测;然而,直接将带有提示的 eGFR 报告引入医生的工作流程,导致在分析的 43 个月内肌酐清除率检测突然显著下降了 23.5%。因此,带有提示的 eGFR 报告可能已经产生了临床实践的改变,因为它直接集成到了医生的工作流程中。改变医生的实践模式可能需要不仅仅是发布指南;更有可能通过教育和结构改变来实现。

相似文献

1
Reporting of the estimated glomerular filtration rate decreased creatinine clearance testing.估算肾小球滤过率估计值检测的报告中,肌酐清除率检测的报告减少。
Kidney Int. 2012 Jun;81(12):1245-7. doi: 10.1038/ki.2011.483. Epub 2012 Feb 15.
2
The cycle of development, publication, and implementation of clinical practice guidelines for CKD.慢性肾脏病临床实践指南的制定、发表和实施周期。
Kidney Int. 2012 Jun;81(12):1159-61. doi: 10.1038/ki.2012.34.
3
Reporting of the estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKD.报告估算肾小球滤过率与 CKD 患者中血管紧张素转换酶抑制剂和血管紧张素 II 受体阻滞剂的使用增加有关。
Kidney Int. 2012 Jun;81(12):1248-53. doi: 10.1038/ki.2012.18. Epub 2012 Mar 21.
4
Clinical practice guidelines for chronic kidney disease in adults: Part II. Glomerular filtration rate, proteinuria, and other markers.成人慢性肾脏病临床实践指南:第二部分。肾小球滤过率、蛋白尿及其他标志物
Am Fam Physician. 2004 Sep 15;70(6):1091-7.
5
Reporting the eGFR and its implication for CKD diagnosis.报告估算肾小球滤过率(eGFR)及其对慢性肾脏病(CKD)诊断的意义。
Clin J Am Soc Nephrol. 2008 Nov;3(6):1606-7. doi: 10.2215/CJN.04560908. Epub 2008 Oct 15.
6
Short-term vitamin D receptor activation increases serum creatinine due to increased production with no effect on the glomerular filtration rate.短期维生素 D 受体激活会导致血清肌酐升高,这是由于产量增加而肾小球滤过率没有影响。
Kidney Int. 2011 Nov;80(10):1073-9. doi: 10.1038/ki.2011.207. Epub 2011 Jun 29.
7
Reporting eGFR.报告估算肾小球滤过率(eGFR)
Clin J Am Soc Nephrol. 2008 Sep;3(5):1561-2. doi: 10.2215/CJN.02870608. Epub 2008 Jul 30.
8
The meaning of urinary creatinine concentration.
Kidney Int. 2011 Apr;79(7):791. doi: 10.1038/ki.2011.1.
9
Improving the clinical value of estimating glomerular filtration rate by reporting all values: a contrarian viewpoint.通过报告所有值来提高估算肾小球滤过率的临床价值:一种反传统观点。
Nephron Clin Pract. 2010;115(3):c177-81. doi: 10.1159/000313030. Epub 2010 Apr 23.
10
Reliability of endogenous markers for estimation of residual renal function in haemodialysis patients.用于评估血液透析患者残余肾功能的内源性标志物的可靠性。
Clin Physiol Funct Imaging. 2013 May;33(3):224-32. doi: 10.1111/cpf.12018. Epub 2013 Jan 1.

引用本文的文献

1
Performance of creatinine-based equations for estimating glomerular filtration rate compared to endogenous creatinine clearance.基于肌酐的方程与内源性肌酐清除率估计肾小球滤过率的性能比较。
J Bras Nefrol. 2022 Apr-Jun;44(2):179-186. doi: 10.1590/2175-8239-JBN-2021-0109.
2
Three Statistical Approaches for Assessment of Intervention Effects: A Primer for Practitioners.评估干预效果的三种统计方法:从业者入门指南。
Risk Manag Healthc Policy. 2021 Feb 22;14:757-770. doi: 10.2147/RMHP.S275831. eCollection 2021.
3
Improving Care for Patients With or at Risk for Chronic Kidney Disease Using Electronic Medical Record Interventions: A Pragmatic Cluster-Randomized Trial Protocol.
使用电子病历干预改善慢性肾脏病患者或慢性肾脏病风险患者的护理:一项实用整群随机试验方案
Can J Kidney Health Dis. 2017 Apr 5;4:2054358117699833. doi: 10.1177/2054358117699833. eCollection 2017.
4
Preanalytical management: serum vacuum tubes validation for routine clinical chemistry.分析前阶段处理:常规临床化学用血清真空采血管验证。
Biochem Med (Zagreb). 2012;22(2):180-6. doi: 10.11613/bm.2012.021.